| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| MousePheno | abnormal Z line morphology | 2.39e-05 | 40 | 20 | 3 | MP:0004091 | |
| MousePheno | abnormal I band morphology | 2.77e-05 | 42 | 20 | 3 | MP:0030567 | |
| Domain | Spectrin | 3.94e-04 | 23 | 24 | 2 | PF00435 | |
| Domain | Spectrin_repeat | 6.29e-04 | 29 | 24 | 2 | IPR002017 | |
| Domain | Spectrin/alpha-actinin | 7.67e-04 | 32 | 24 | 2 | IPR018159 | |
| Domain | SPEC | 7.67e-04 | 32 | 24 | 2 | SM00150 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | 1.75e-04 | 439 | 18 | 5 | MM15595 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | 1.97e-04 | 450 | 18 | 5 | M27078 | |
| Pubmed | 1.95e-07 | 17 | 24 | 3 | 15767674 | ||
| Pubmed | 4.56e-06 | 5 | 24 | 2 | 19398467 | ||
| Pubmed | 1.98e-05 | 497 | 24 | 5 | 23414517 | ||
| Pubmed | Ikaros DNA-binding proteins direct formation of chromatin remodeling complexes in lymphocytes. | 2.50e-05 | 11 | 24 | 2 | 10204490 | |
| Pubmed | 3.00e-05 | 12 | 24 | 2 | 36793866 | ||
| Pubmed | A molecular dissection of the repression circuitry of Ikaros. | 4.13e-05 | 14 | 24 | 2 | 12015313 | |
| Pubmed | RUNX proteins desensitize multiple myeloma to lenalidomide via protecting IKZFs from degradation. | 5.44e-05 | 16 | 24 | 2 | 30760870 | |
| Pubmed | Inherited genetic variant predisposes to aggressive but not indolent prostate cancer. | 1.96e-04 | 30 | 24 | 2 | 20080650 | |
| Pubmed | 1.96e-04 | 30 | 24 | 2 | 18055048 | ||
| Pubmed | 2.27e-04 | 173 | 24 | 3 | 36217029 | ||
| Pubmed | 6.87e-04 | 56 | 24 | 2 | 23934736 | ||
| Interaction | PROZ interactions | 8.67e-06 | 34 | 24 | 3 | int:PROZ | |
| Coexpression | TSUTSUMI_FBXW8_TARGETS | 2.88e-05 | 9 | 24 | 2 | M2187 | |
| Coexpression | TSUTSUMI_FBXW8_TARGETS | 2.88e-05 | 9 | 24 | 2 | MM888 | |
| Coexpression | GSE11057_EFF_MEM_VS_CENT_MEM_CD4_TCELL_UP | 3.04e-05 | 199 | 24 | 4 | M3111 | |
| CoexpressionAtlas | ratio_StemCell_vs_induced-DefinitiveEndoderm_top-relative-expression-ranked_500_k-means-cluster#5 | 9.66e-06 | 262 | 24 | 5 | ratio_SC_vs_DE_500_K5 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.68e-06 | 199 | 24 | 4 | 05777e92344aedabfb5a72207c6632dc64205534 | |
| ToppCell | COVID-19_Mild-Neu_1|World / 5 Neutrophil clusters in COVID-19 patients | 4.06e-05 | 125 | 24 | 3 | e58c208b4355252ceabe04a468dd19a1f436182c | |
| ToppCell | COVID-19_Mild|World / 5 Neutrophil clusters in COVID-19 patients | 7.26e-05 | 152 | 24 | 3 | 2ff0980dfd8d430cca14649151d856edef115720 | |
| ToppCell | Healthy_Control-Myeloid-Macrophages-|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 8.61e-05 | 161 | 24 | 3 | d0482666479530cd2fd0d229cbb59a1d79839477 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|kidney / Disease (COVID-19 only), tissue and cell type | 8.93e-05 | 163 | 24 | 3 | 19c28ce16a588a7f4a035c32726f6ccd67702b5b | |
| ToppCell | facs-Heart-RA-18m-Lymphocytic-B_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.43e-05 | 166 | 24 | 3 | fc2cf67311c86fda75b35fcd4768b6f6f14c59d0 | |
| ToppCell | facs-Heart-RA-18m-Lymphocytic-B_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.43e-05 | 166 | 24 | 3 | 33a6876d06e26176135a73a77c19e634ec53f7ce | |
| ToppCell | COVID-19_Severe-CD4+_CTL|World / disease group, cell group and cell class | 9.94e-05 | 169 | 24 | 3 | 8c8168ac93a808d7b4756e4491db2b2979df1c1f | |
| ToppCell | LPS-IL1RA-Lymphocytic_NKT-T_cells-T-cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.03e-04 | 171 | 24 | 3 | 539ea88acc6f948efdeae8b69e5c5ffaee29f1d9 | |
| ToppCell | COVID-19-Heart-T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.03e-04 | 171 | 24 | 3 | b2e753e811a7639956994609f73efcdb62d04f82 | |
| ToppCell | LPS-IL1RA-Lymphocytic_NKT-T_cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.05e-04 | 172 | 24 | 3 | 0fc692be845d4225ff8b63bf9195724fc8510c2c | |
| ToppCell | Children_(3_yrs)-Immune-natural_killer_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.08e-04 | 174 | 24 | 3 | 33d6b81f31bfcb9c4b30206d88e20b9a94fba4a2 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-04 | 174 | 24 | 3 | fbf998dd33ac27dad7639ea85fca393ba2835307 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-04 | 174 | 24 | 3 | 8bdf5a97faf1cf0426d1a8851f8a3e27578f7598 | |
| ToppCell | facs-Marrow-B-cells-18m-Hematologic-Unknown_Progenitor|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-04 | 176 | 24 | 3 | 5f9ae5eb45603ed0422a3a993ecdbe2ce05d6e45 | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_NKT-T_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.12e-04 | 176 | 24 | 3 | bb41e9478373726eb460af764de0277b2d09928e | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_NKT-T_cells-T-cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.12e-04 | 176 | 24 | 3 | 9d4a4dfeebb5a8a0f3ab18c37c8ddc2cd2158575 | |
| ToppCell | LPS-antiTNF-Lymphocytic_NKT-T_cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.12e-04 | 176 | 24 | 3 | ea27e18407b8a13e8212830da859efeb8f158690 | |
| ToppCell | LPS-antiTNF-Lymphocytic_NKT-T_cells-T-cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.12e-04 | 176 | 24 | 3 | bfbab3c5b738b3b0b1540f2059d0245fbd8c0031 | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.14e-04 | 177 | 24 | 3 | 84591e28482ab62a5ef41e61043eb64912766356 | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_NKT|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.14e-04 | 177 | 24 | 3 | f1efd9c3074d5635700fe7fbebf3dd0b1e0a84f1 | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet-Megakaryocyte/Platelet_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.14e-04 | 177 | 24 | 3 | 4bc100062891d07cacd10ffba38966cc6302c92f | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.14e-04 | 177 | 24 | 3 | 9f3a2adb9cd4f0a059afc87b6e377a9702154bb1 | |
| ToppCell | PND01-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_G2M|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.18e-04 | 179 | 24 | 3 | df4d0b2fe47d2c7def729b3217cb01ced01495ff | |
| ToppCell | LPS-antiTNF-Lymphocytic_NKT|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.18e-04 | 179 | 24 | 3 | ecea75c568911ff56939c9f67ab901497bd4356c | |
| ToppCell | LPS-IL1RA-Lymphocytic_NKT|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.18e-04 | 179 | 24 | 3 | 5ccf0824611ded5c673d94dff3048aedac12f1a8 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.20e-04 | 180 | 24 | 3 | ca2a35bfb67347e47f511589a3d0f763e6664634 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet-Megakaryocyte/Platelet_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.20e-04 | 180 | 24 | 3 | 4e9e8cde2919610c4ac0025b1c9819808048bc1d | |
| ToppCell | LPS_only-Lymphocytic_NKT-T_cells-T-cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.20e-04 | 180 | 24 | 3 | dcef253f2e97e4436b1b04e8a06a53ff6e64522c | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.20e-04 | 180 | 24 | 3 | 466381bf93c3da6a2a241daadb68e9aad2964eae | |
| ToppCell | LPS_only-Lymphocytic_NKT-T_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.22e-04 | 181 | 24 | 3 | a4347ae554e6dcf03c7001a2b69332b377c7c034 | |
| ToppCell | droplet-Marrow-nan-18m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-04 | 185 | 24 | 3 | 238938a4682b44e88a30b86b13af4feeabe9553d | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.34e-04 | 187 | 24 | 3 | a9316e2818217ec5feae9cf8816f7249803caee6 | |
| ToppCell | LPS_only-Lymphocytic_NKT|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.36e-04 | 188 | 24 | 3 | bbe65b1c11c88ab62d8485cfc3a913ff9da89aad | |
| ToppCell | background-Endothelial_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.52e-04 | 195 | 24 | 3 | c7d60dabfc7cb310e002cab10003dadfcc34fe33 | |
| ToppCell | Control-PLT_1|Control / Disease Group and Platelet Clusters | 1.52e-04 | 195 | 24 | 3 | 20ee45983a5675d9fa072d02dd45c6ce8662d7d7 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.52e-04 | 195 | 24 | 3 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.52e-04 | 195 | 24 | 3 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | background-Endothelial_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 1.54e-04 | 196 | 24 | 3 | e6fb0bfab1779ec64a8c35d01519eaafbf62e977 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-B-B_cell-B_naive|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.54e-04 | 196 | 24 | 3 | de43dd0697e1daf4d50800957cf0b27b54a7a333 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.56e-04 | 197 | 24 | 3 | d9e196c8b4a6ede4733946dbdba3331534954beb | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.61e-04 | 199 | 24 | 3 | 137ff58897e6ada8a5a70205f66fe9110795506b | |
| ToppCell | PBMC-Severe-cDC_9|Severe / Compartment, Disease Groups and Clusters | 1.63e-04 | 200 | 24 | 3 | ea3b22126d9dfd158bb3c3e1323b30514d721ded | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Fezf2-Excitatory_Neuron.Slc17a7-Slc17a6.Fezf2-3110035E14Rik_(Layer_5,_Retrosplenial_cortex_(RSG)_and_Subiculum,_Tshz2+)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 7.20e-04 | 74 | 24 | 2 | 83b762542508f9d6407e4b0087d70bea81a8fc7d | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Nxph3-Excitatory_Neuron.Slc17a7-Slc17a6.Nxph3-Nts_(Subiculum)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 7.59e-04 | 76 | 24 | 2 | 355a6793e2828728da62357bd2250735b0fd76b1 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Nxph3-Excitatory_Neuron.Slc17a7-Slc17a6.Nxph3-Nts_(Subiculum)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 7.59e-04 | 76 | 24 | 2 | 2c304b41c04a567874126df25b15d8ee2ad2b6d9 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Fezf2|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 9.92e-04 | 87 | 24 | 2 | aaca22b97a42a1c4a10c5da708d1462101814386 | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-NK-ILC-T_NK-NK_CD11d|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.92e-04 | 87 | 24 | 2 | f92e08c2d1c2f216063ecfd42b06652e558c1a89 | |
| ToppCell | Thalamus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a7-Tac2-Excitatory_Neuron.Slc17a7.Tac2.Htr2c_(Lateral_habenula)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.28e-03 | 99 | 24 | 2 | 3dd31ed90bd1655cad954045afaef50de889008b | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Lymphocytic-B-B_cell-B_naive|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.33e-03 | 101 | 24 | 2 | 86acaa2502f61baa714ae988b73e3e73a71e897e | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Otx2_(ventral_lateral_geniculate_nucleus,_magnocellular_part_(VLGMC)?)--|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.44e-03 | 105 | 24 | 2 | c7528276fee8f6d2cb4639069bc87413b0288025 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Otx2_(ventral_lateral_geniculate_nucleus,_magnocellular_part_(VLGMC)?)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.44e-03 | 105 | 24 | 2 | 7bcf3345a21a1ade717128be127e9fe12ae40011 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Otx2_(ventral_lateral_geniculate_nucleus,_magnocellular_part_(VLGMC)?)-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.44e-03 | 105 | 24 | 2 | 62e89b92bb8c5187ab0205aebd018b4178710bb0 | |
| ToppCell | Mild/Remission-B_naive-12|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.49e-03 | 107 | 24 | 2 | 1ab09acb66e4282688fd1f6782a4009f4ea18c41 | |
| ToppCell | Mild/Remission-B_naive-12|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.52e-03 | 108 | 24 | 2 | 9c25d199e7d7389c84ff32712eee7e728a4c55cc | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.72e-03 | 115 | 24 | 2 | 207d464c09caf9be361daa56c83cd7da5cf9ce47 | |
| ToppCell | PND07-28-samps-Lymphocyte-T_cells-T_cells_1|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.81e-03 | 118 | 24 | 2 | 461a971f3e8047c727b7c6e00d2d64e97d50c6de | |
| ToppCell | COVID-19_Mild-Neutrophil-|COVID-19_Mild / Disease condition and Cell class | 1.94e-03 | 122 | 24 | 2 | 6ce3e9e2868d6cdc4ed90b90b2541b8f51270cac | |
| ToppCell | COVID-19_Mild-Neutrophil|COVID-19_Mild / Disease condition and Cell class | 1.94e-03 | 122 | 24 | 2 | bc4346f4caaed153583b0fe8521b45437f5c3049 | |
| ToppCell | LPS-IL1RA-Endothelial-Epi-like-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.09e-03 | 127 | 24 | 2 | 6b24630978eb0772b4cd3bf59e5bc4390be47619 | |
| ToppCell | LPS-IL1RA-Lymphocytic_NKT-T_cells-Erythroid|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.13e-03 | 128 | 24 | 2 | c2045f052cc713e52312eb015825711576fcb6c5 | |
| ToppCell | Ionocyte-iono-4|World / Class top | 2.16e-03 | 129 | 24 | 2 | 85ee6e16959cb58a58f5b09edf1f78d9ce6a9441 | |
| ToppCell | COVID-19-B_cells-B_cells|COVID-19 / group, cell type (main and fine annotations) | 2.19e-03 | 130 | 24 | 2 | 267b06a0db31e2664cf595cd737402da07ab51cd | |
| ToppCell | BAL-Severe-cDC_6|Severe / Compartment, Disease Groups and Clusters | 2.19e-03 | 130 | 24 | 2 | 4104d1e10609331b67db3b85c63537aec58b1713 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.43e-03 | 137 | 24 | 2 | 761cc0e2b4971e98f6d0691d4575b5cd208b602d | |
| ToppCell | LPS-IL1RA-Lymphocytic_NKT-iNKT/MAIT-T-cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.50e-03 | 139 | 24 | 2 | ecc2a6ecc27748c50885cd4f0ad8a8cd1252aee6 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(EC)|kidney / Disease (COVID-19 only), tissue and cell type | 2.50e-03 | 139 | 24 | 2 | 64c35411bbe67acb5010dadc4b0b1be0f8b17737 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_PT|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.54e-03 | 140 | 24 | 2 | 7cc891d676555609add6fc7880735d948a2ad801 | |
| ToppCell | LPS-antiTNF-Lymphocytic_NKT-T_cells-iNKT-MAIT|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.54e-03 | 140 | 24 | 2 | a8f3b01d03ee0bf0e752327a98d6b9035930c2b0 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig-Z|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.64e-03 | 143 | 24 | 2 | eb11ff288cb91210383b288aa57715ebd59a52c3 | |
| ToppCell | P03-Hematopoietic-Erythroid|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.68e-03 | 144 | 24 | 2 | 2ee6a834860eac7ed004f366ab4fc38c4b80c905 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.68e-03 | 144 | 24 | 2 | 1c001a5a3bbe4ecbce8305f8b260e933033550dd | |
| ToppCell | P03-Hematopoietic-Erythroid-enucleate_erythrocyte|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.68e-03 | 144 | 24 | 2 | 9fa63904389f4d7163db22ea85ab721d8f6e8d99 | |
| ToppCell | COVID-19-Heart-CM_5_(RYR2-)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.68e-03 | 144 | 24 | 2 | f92e03dd784e31a9e5dbd4f4c3a6517ea19210cf | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-T_lymphocytic-regulatory_T_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.75e-03 | 146 | 24 | 2 | 7748277cf2f12e2930d4f5a22247ab9bc266a954 | |
| ToppCell | Lymphoid-B_cells|World / shred on cell class and cell subclass (v4) | 2.79e-03 | 147 | 24 | 2 | aa4486200c523f2c9d3bad7a14f1764c2d92076b | |
| ToppCell | COVID-19-kidney-Lymphatic_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.83e-03 | 148 | 24 | 2 | f777aa1674e898e2594b2b7c029d3d05dda04df9 | |
| ToppCell | PND01-Immune-Immune_Lymphocytic_T/NK|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.83e-03 | 148 | 24 | 2 | b78dac56b333bf901136ccafb0999f345e978f51 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.87e-03 | 149 | 24 | 2 | defe2e4a2f3118f8b42e99a4f2bf03e54c1b698f | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.90e-03 | 150 | 24 | 2 | 0205318a870e091add66ee4305747dda9f51510d | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-CD4-positive,_alpha-beta_T_cell-CD4_T_cells-CD4_T_cells_L.1.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.90e-03 | 150 | 24 | 2 | 207fc230d7721149c7afc7970dd56817f52801d8 | |
| ToppCell | PND01-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.94e-03 | 151 | 24 | 2 | ee56b88c56c3b6a5ec9644c43cae521ea0e05920 | |
| ToppCell | PND01-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.94e-03 | 151 | 24 | 2 | 2c239b09970acbaa90c5ebe1097f453c516f868e | |
| ToppCell | Control-Lymphocytic_NKT-T_cells-iNKT-MAIT|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.94e-03 | 151 | 24 | 2 | 7e5e35ce601ca3d3722063566e89664909171b8d | |
| ToppCell | PND01-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.98e-03 | 152 | 24 | 2 | b750302d442160a1007659c2386ac90282bf95d2 | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal-valve_cells|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.02e-03 | 153 | 24 | 2 | 1440f2716fea74e2c3eb2924eba3d63ebd08c997 | |
| ToppCell | PBMC-Control-cDC_8|Control / Compartment, Disease Groups and Clusters | 3.02e-03 | 153 | 24 | 2 | db1a6914f2033fb0748e0523cffe5d6dc4e901be | |
| ToppCell | RV-17._Lymphocyte|RV / Chamber and Cluster_Paper | 3.02e-03 | 153 | 24 | 2 | e1ea621184014415870e00d511386b8cc3e0833b | |
| ToppCell | TCGA-Thryoid-Solid_Tissue_Normal-Thryoid_normal_tissue-Thryoid_normal_tissue-3|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 3.06e-03 | 154 | 24 | 2 | 4e9203c220a44c70cd7979796a0b461991422257 | |
| ToppCell | COVID-19-kidney-Mito-rich_(Imm)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.06e-03 | 154 | 24 | 2 | b437acc11e35fe05389e552d507f6f76e20cc102 | |
| ToppCell | COVID-19-Heart-CM_5_(RYR2-)|Heart / Disease (COVID-19 only), tissue and cell type | 3.10e-03 | 155 | 24 | 2 | d7e26696fd9c0a759524f331243db43059b33ed9 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Granulocytic|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.10e-03 | 155 | 24 | 2 | 51f6447945389649d99dcf7603b396195c631ead | |
| ToppCell | E18.5-Immune-Immune_Lymphocytic_T/NK|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.10e-03 | 155 | 24 | 2 | efe69145910c5e049d0ed30699c26ef963e0a285 | |
| ToppCell | E18.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.10e-03 | 155 | 24 | 2 | d8e9f355ce933f6383c3d1e35ff55235a95c7fcd | |
| ToppCell | Fetal_29-31_weeks-Immune-dendritic_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.10e-03 | 155 | 24 | 2 | 9f937ae48767fdcf1a944af4de0530d9c0ab441d | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_T_CD4-Tregs|GI_small-bowel / Manually curated celltypes from each tissue | 3.10e-03 | 155 | 24 | 2 | d4ef25965a15eab7679478b9b661e1b4a92f1c59 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Granulocytic-Mast_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.10e-03 | 155 | 24 | 2 | 23dc71cab28094ca0ac4d2baf4e24871ed107781 | |
| ToppCell | RV-17._Lymphocyte|World / Chamber and Cluster_Paper | 3.10e-03 | 155 | 24 | 2 | 189276a3b400b2202e6681e23732e6452bfe704e | |
| ToppCell | facs-Brain_Myeloid-Cortex_-18m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.14e-03 | 156 | 24 | 2 | 2ba838bc864c2c1767bcab7bb4d790af96b91387 | |
| ToppCell | E18.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.14e-03 | 156 | 24 | 2 | 44ff0acdd5cc3575d6c24a1c2ba11cd9f55359d1 | |
| Disease | marginal zone B-cell lymphoma, systemic lupus erythematosus | 5.80e-06 | 5 | 23 | 2 | EFO_1000630, MONDO_0007915 | |
| Disease | Endometrial Neoplasms | 9.36e-04 | 58 | 23 | 2 | C0014170 | |
| Disease | Endometrial Carcinoma | 1.44e-03 | 72 | 23 | 2 | C0476089 | |
| Disease | hypothyroidism (biomarker_via_orthology) | 1.77e-03 | 80 | 23 | 2 | DOID:1459 (biomarker_via_orthology) | |
| Disease | platelet-to-lymphocyte ratio | 2.72e-03 | 363 | 23 | 3 | EFO_0008446 | |
| Disease | lower face morphology measurement | 3.25e-03 | 109 | 23 | 2 | EFO_0010948 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MKRSRNHIMGRYFSN | 971 | A4D0V7 | |
| TANRMLKQMLFRYQG | 121 | Q99436 | |
| HFAMNSMNAYVNINR | 356 | O60229 | |
| MRFKNRFQRFMNHRA | 1 | Q15546 | |
| RKQNYMMNFSRQHGL | 3431 | P78509 | |
| MMNFSRQHGLRHFYN | 3436 | P78509 | |
| GNHKNRVNMTYEKMS | 266 | Q9Y603 | |
| MYFMKNRARRQGINL | 306 | Q9NWK9 | |
| MYMQNALKEQQHGAL | 456 | Q8N4M1 | |
| YQQNHMVLSRARNGM | 401 | Q9UKT9 | |
| HCQVMFRNYQRKNDM | 566 | Q14839 | |
| MNNKVFYQHPNLMRA | 2186 | P21817 | |
| VRKQNVQFMHNRMQY | 1991 | Q93008 | |
| NSNQFGIMMYHNNRL | 326 | Q8TE76 | |
| NFTQQHMPYFRKRMV | 621 | Q9P0U3 | |
| MSGYKRMRRQHQKQL | 461 | Q9H2K8 | |
| NKAAALQRRMSMYSQ | 331 | Q9Y4F9 | |
| RASFNHFDRKQNGMM | 766 | Q08043 | |
| YSCNQSMNLKRHMLR | 451 | Q8N8E2 | |
| KMSYLQMRNSQAHRN | 206 | Q9BXS4 | |
| GKFFRMKMTLNNHQR | 336 | P51786 | |
| GSSYRHMRNMKGLRQ | 11 | P49675 | |
| NMRNYMQKLERNFGQ | 81 | P58340 | |
| KQGMASLFRYMQQNS | 276 | Q9BR11 | |
| MNNSAALRHGAVMYQ | 121 | Q05996 |